| 臺大學術典藏 |
2020-05-15T07:01:34Z |
Downhole fiber optic temperature-pressure innovative measuring system used in Sanshing geothermal test site
|
Yu, C.-W.; Lei, S.-C.; Chen, W.-S.; Song, S.-R.; WEN-SHAN CHEN |
| 臺大學術典藏 |
2020-05-15T07:01:33Z |
Scenario analysis on operational productivity for target EGS reservoir in I-lan area, Taiwan
|
Yu, C.-W.; Lei, S.-C.; Yang, C.-H.; Chen, W.-S.; Song, S.-R.; WEN-SHAN CHEN |
| 臺大學術典藏 |
2020-05-12T06:43:08Z |
Antioxidant activity, delayed aging, and reduced amyloid-β toxicity of methanol extracts of tea seed pomace from camellia tenuifolia
|
Liao V.H.-C.; Hsu F.-L.; Chang S.-T.; Lin H.-Y.; Yen P.-L.; Yu C.-W.; CHIA-CHENG WEI; Chia-Cheng Wei;Yu C.-W.;Yen P.-L.;Lin H.-Y.;Chang S.-T.;Hsu F.-L.;Liao V.H.-C. |
| 臺大學術典藏 |
2020-05-12T06:43:08Z |
Curcumin-mediated oxidative stress resistance in Caenorhabditis elegans is modulated by age-1, akt-1, pdk-1, osr-1, unc-43, sek-1, skn-1, sir-2.1, and mev-1
|
Yu C.-W.;Chia-Cheng Wei;Liao V.H.-C.; Yu C.-W.; CHIA-CHENG WEI; Liao V.H.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:14Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Yu C.-W.; Hsu C.-Y.; Chen B.-B.; Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Hsu C.;Chih-Hung Hsu;Cheng A.-L.;Shih T.T.-F.; Liang P.-C.; Hsu C.; CHIH-HUNG HSU; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-04-16T02:35:11Z |
An effective output-oriented algorithm for low power multipartition architecture
|
Ruan, S.-J.; Lin, J.-C.; Chen, P.-H.; Lai, F.; Tsai, K.-L.; Yu, C.-W.; FEI-PEI LAI |
| 臺大學術典藏 |
2020-04-10T12:51:16Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-H.; Hu F.-C.; Hsu C.-Y. ;Shen Y.-C. ;Yu C.-W. ;Chiun Hsu ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; Hsu C.-Y.; Shen Y.-C.; Yu C.-W.; Chiun Hsu; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-04-10T12:51:14Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Chiun Hsu;Yang T.-S.;Huo T.-I.;Hsieh R.-K.;Yu C.-W.;Hwang W.-S.;Hsieh T.-Y.;Huang W.-T.;Chao Y.;Meng R.;Cheng A.-L.; Chiun Hsu; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:04Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Shih T.T.-F.; Cheng A.-L.; Hsu C.-H.; Chiun Hsu; Liang P.-C.; Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Chiun Hsu;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W. |
| 臺大學術典藏 |
2020-04-10T12:51:01Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Chiun Hsu;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Chiun Hsu; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
